JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has maintained a Market Outperform rating on TELA Bio (NASDAQ:TELA), but has reduced the price target from $20 to $15.
November 10, 2023 | 7:52 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JMP Securities reaffirmed a Market Outperform rating on TELA Bio, but lowered the price target from $20 to $15, indicating a potential downside compared to the previous target.
The reduction in price target by JMP Securities suggests that they see less upside potential for TELA Bio's stock price in the short term. This could lead to a negative investor sentiment and a potential decrease in the stock price as the market adjusts to the new analyst expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100